These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4911247)
61. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells. Bennett M J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320 [No Abstract] [Full Text] [Related]
62. Histocompatibility genes of mice. VII. H-13, a new histocompatibility locus in the fifth linkage group. Snell GD; Cudkowicz G; Bunker HP Transplantation; 1967 May; 5(3):492-503. PubMed ID: 5340356 [No Abstract] [Full Text] [Related]
63. Experience with passive enhancement of renal allografts in A (DA x Lewis)F 1 to Lewis Strain combination. Fabre JW; Morris PJ Transplantation; 1972 Jun; 13(6):604-9. PubMed ID: 4556072 [No Abstract] [Full Text] [Related]
64. Passive antibody delays development of cell-mediated immunity in rats receiving renal allografts. Biesecker JL; Fitch FW; Rowley DA; Stuart FP Transplant Proc; 1973 Mar; 5(1):667-9. PubMed ID: 4572125 [No Abstract] [Full Text] [Related]
65. Alpha-2-globulins in renal graft rejection. Effects of in vitro lymphocyte function. Riggio RR; Schwartz GH; Bull FG; Stenzel KH; Rubin AL Transplantation; 1969 Nov; 8(5):689-94. PubMed ID: 4101661 [No Abstract] [Full Text] [Related]
66. Effect of antilymphocyte serum on the thymus. Levey RH; Taub R Transplant Proc; 1969 Mar; 1(1):424-8. PubMed ID: 4944253 [No Abstract] [Full Text] [Related]
67. Allograft immunity in vitro. IV. Proliferative response and effector mechanism in mixed cultures of mouse blood lymphocytes. Häyry P; Virolainen M; Defendi V Transplant Proc; 1971 Mar; 3(1):876-8. PubMed ID: 5095894 [No Abstract] [Full Text] [Related]
71. The current status of histocompatibility tests in renal transplantation. Morris PJ Med J Aust; 1968 Jun; 1(25):1100-3. PubMed ID: 4875447 [No Abstract] [Full Text] [Related]
72. Use of L-phenylalanine mustard (Alkeran) in canine renal allografts. Varkarakis MJ; Greco JM; Murphy GP J Med; 1973; 4(2):82-7. PubMed ID: 4584071 [No Abstract] [Full Text] [Related]
74. The reactivity of murine lymphocytes to epidermal cells. Gillette RW; Cooper S; Lance EM Immunology; 1972 Nov; 23(5):769-76. PubMed ID: 4564554 [TBL] [Abstract][Full Text] [Related]
75. Immunosuppression by chemical agents. Bach JF Transplant Proc; 1971 Mar; 3(1):27-33. PubMed ID: 4937894 [No Abstract] [Full Text] [Related]
76. Early evaluation of cadaver renal allotransplant by means of radionuclide imaging. Staab EV; Whittier F; Patton DD; Ginn EH; Ackerman JR Radiology; 1973 Jan; 106(1):147-51. PubMed ID: 4566354 [No Abstract] [Full Text] [Related]
77. The new serology of histocompatibility testing and its significance in human renal transplantation. Braun WE Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083 [No Abstract] [Full Text] [Related]
78. A heterophile system in human renal transplantation. II. Relationship to clinical renal transplantation and the HL-A system. McDonald JC Transplantation; 1973 Jan; 15(1):123-8. PubMed ID: 4575918 [No Abstract] [Full Text] [Related]